Drug Shortage Report for ACTONEL DR
| Report ID | 95288 |
| Drug Identification Number | 02370417 |
| Brand name | ACTONEL DR |
| Common or Proper name | risedronate |
| Company Name | ALLERGAN INC |
| Market Status | MARKETED |
| Active Ingredient(s) | RISEDRONATE SODIUM |
| Strength(s) | 35MG |
| Dosage form(s) | TABLET (DELAYED-RELEASE) |
| Route of administration | ORAL |
| Packaging size | 4 |
| ATC code | M05BA |
| ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2019-10-07 |
| Actual start date | 2019-10-04 |
| Estimated end date | 2019-10-21 |
| Actual end date | 2019-10-03 |
| Shortage status | Avoided shortage |
| Updated date | 2019-10-03 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2019-10-03 | French | Compare |
| v3 | 2019-10-03 | English | Compare |
| v2 | 2019-10-03 | French | Compare |
| v1 | 2019-10-03 | English | Compare |
Showing 1 to 4 of 4